To investigate the molecular mechanism underlying Mel’s effect on pancreatic cancer, protein levels of p62 and Keap1 were measured in rats co-treated with Mel, Gem, or their combination. The gene discussed is KEAP1; the disease is familial pancreatic carcinoma.